Thomas G Wiggans - Net Worth and Insider Trading

Thomas G Wiggans Net Worth

The estimated net worth of Thomas G Wiggans is at least $5 Million dollars as of 2024-03-29. Thomas G Wiggans is the CEO & Chairman of the Board of Dermira Inc and owns about 256,925 shares of Dermira Inc (DERM) stock worth over $5 Million. Thomas G Wiggans is the Director of Jasper Therapeutics Inc and owns about 5,000 shares of Jasper Therapeutics Inc (JSPR) stock worth over $146,800. Thomas G Wiggans is also the CEO of Pardes Biosciences Inc and owns about 50,000 shares of Pardes Biosciences Inc (PRDS) stock worth over $108,000. Details can be seen in Thomas G Wiggans's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas G Wiggans has not made any transactions after 2023-11-28 and currently still holds the listed stock(s).

Transaction Summary of Thomas G Wiggans

To

Thomas G Wiggans Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas G Wiggans owns 7 companies in total, including Forma Therapeutics Holdings Inc () , Annexon Inc () , and Dermira Inc () among others .

Click here to see the complete history of Thomas G Wiggans’s form 4 insider trades.

Insider Ownership Summary of Thomas G Wiggans

Ticker Comapny Transaction Date Type of Owner
Forma Therapeutics Holdings Inc 2020-09-07 director
Annexon Inc 2020-07-23 director
Dermira Inc 2020-02-20 director & CEO & Chairman of the Board
Sangamo Therapeutics Inc 2008-06-04 director
CymaBay Therapeutics Inc 2022-01-25 director
Pardes Biosciences Inc 2022-12-05 director & Chief Executive Officer
Jasper Therapeutics Inc 2023-11-28 director

Thomas G Wiggans Latest Holdings Summary

Thomas G Wiggans currently owns a total of 3 stocks. Among these stocks, Thomas G Wiggans owns 256,925 shares of Dermira Inc (DERM) as of August 19, 2019, with a value of $5 Million and a weighting of 94.98%. Thomas G Wiggans owns 5,000 shares of Jasper Therapeutics Inc (JSPR) as of November 28, 2023, with a value of $146,800 and a weighting of 2.89%. Thomas G Wiggans also owns 50,000 shares of Pardes Biosciences Inc (PRDS) as of December 5, 2022, with a value of $108,000 and a weighting of 2.13%.

Latest Holdings of Thomas G Wiggans

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DERM Dermira Inc 2019-08-19 256,925 18.75 4,817,344
JSPR Jasper Therapeutics Inc 2023-11-28 5,000 29.36 146,800
PRDS Pardes Biosciences Inc 2022-12-05 50,000 2.16 108,000

Holding Weightings of Thomas G Wiggans


Thomas G Wiggans Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas G Wiggans has made a total of 1 transactions in Dermira Inc (DERM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Dermira Inc is the acquisition of 23,419 shares on August 19, 2019, which cost Thomas G Wiggans around $199,998.

According to the SEC Form 4 filings, Thomas G Wiggans has made a total of 3 transactions in Jasper Therapeutics Inc (JSPR) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Jasper Therapeutics Inc is the acquisition of 1,000 shares on November 28, 2023, which cost Thomas G Wiggans around $6,500.

According to the SEC Form 4 filings, Thomas G Wiggans has made a total of 2 transactions in Pardes Biosciences Inc (PRDS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Pardes Biosciences Inc is the acquisition of 12,500 shares on December 5, 2022, which cost Thomas G Wiggans around $13,625.

Insider Trading History of Thomas G Wiggans

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas G Wiggans Trading Performance

GuruFocus tracks the stock performance after each of Thomas G Wiggans's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas G Wiggans is 73.92%. GuruFocus also compares Thomas G Wiggans's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas G Wiggans within 3 months outperforms 8 times out of 10 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Thomas G Wiggans's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Thomas G Wiggans

Average Relative Return

-3.89%

Average relative return per transaction

Outperforming Transactions

25%

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 12.65 73.92 25.64 -3.89
Relative Return to S&P 500(%) 10.88 68.03 26.91 -11.04

Thomas G Wiggans Ownership Network

Ownership Network List of Thomas G Wiggans

No Data

Ownership Network Relation of Thomas G Wiggans


Thomas G Wiggans Owned Company Details

What does Forma Therapeutics Holdings Inc do?

Who are the key executives at Forma Therapeutics Holdings Inc?

Thomas G Wiggans is the director of Forma Therapeutics Holdings Inc. Other key executives at Forma Therapeutics Holdings Inc include EVP & Research & Development Agustin Melian , SVP & Chief Scientific Officer David N Cook , and SVP & Chief Financial Officer Todd Shegog .

Forma Therapeutics Holdings Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Forma Therapeutics Holdings Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Forma Therapeutics Holdings Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Forma Therapeutics Holdings Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Forma Therapeutics Holdings Inc Insider Transactions

No Available Data

Thomas G Wiggans Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas G Wiggans. Currently GuruFocus does not have mailing address information for Thomas G Wiggans.

Discussions on Thomas G Wiggans

No discussions yet.